Jian Zhang(张健)
Professor
Molecular Design Laboratory
Institute of Medical Science, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, School of Medicine, Shanghai Jiao Tong University;College of Basic Medical Sciences, Shanghai Jiao Tong University
Follow
Claim
分享
Follow
Claim
分享
基本信息
views: 665
Career Trajectory
Bio
研究方向与进展:主要从事药物设计、药物化学和化学生物学研究,特别是精准靶标识别和First-in-class原创药物先导发现等方向做出了一系列突破性成果。以通讯作者在包括Nat Chem Biol, Sci Adv, Am J Hum Genet, Nucleic Acids Res, Chem Sci等国际学术杂志上发表SCI论文100余篇。近年来代表性工作包括:(1)发展临床样本靶标识别方法识别抗肿瘤新靶标(Am J Hum Genet, 2017; Nucleic Acids Res, 2020);(2)发展变构药物设计方法发现多种全新变构活性分子(Nucleic Acids Res, 2011, 2014, 2016, 2018, 2019; Chem Sci, 2020);(3)研发抗肿瘤新靶标首个First-in-class药物先导,如SIRT6激动剂MDL-800、APC/Asef互作抑制剂MAIT-203等 (Nat Chem Biol, 2017, 2018; Sci Adv, 2019)。他引超过5000次,H因子为45,第一发明人申请国内外专利13项(已授权6项)。受邀以通讯作者在国际顶尖综述杂志Chem Rev (IF=54.3)、Chem Soc Rev (IF=40.2)撰写变构药物机制综述,均作为封面文章重点推荐;受美国化学会旗舰期刊Acc Chem Res (IF=20.9)特邀回顾申请人10年来引领变构药物设计领域发展的贡献;受Springer-Nature出版社邀请作为主编撰写国际首本变构药物发现专著Protein Allostery in Drug Discovery;常年担任Science、Nat Chem等70余种SCI期刊审稿人,澳大利亚FWF、新加坡IAF-PP等基金和西班牙University of Barcelona等学校Tenure考核的国际评审人。由于在“精准靶标识别和First-in-class药物先导发现”方面的贡献,获美国化学会Excellent Research Advisor、中国药学会生物医药创新奖、2017年中国十大科技新锐人物、Roche Creative Chemistry Award和药明康德生命化学研究奖等荣誉。现任国家卫健委卫生健康高级人才评价专家、中国化学会、中国药学会、中国医师协会精准医学委员会等专委会委员。
Research Interests
Papers共 379 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Hongyue Liu, Pengfei Yan, Zhaoyu Zhang, Hongbo Han,Qingtong Zhou, Jie Zheng,Jian Zhang,Fei Xu,Wenqing Shui
Journal of the American Chemical Societyno. 35 (2024): 24726-24726
Tian-Yi Zhang, Yao-Qi Chen,Jing-Cong Tan, Jin-An Zhou,Wan-Ning Chen,Tong Jiang,Jin-Yin Zha, Xiang-Kang Zeng,Bo-Wen Li,Lu-Qi Wei,Yun Zou,Lu-Yao Zhang,Yue-Mei Hong,Xiu-Li Wang, Run-Ze Zhu,Wan-Xing Xu,Jing Xi,Qin-Qin Wang,Lei Pan,Jian Zhang,Yang Luan,Rui-Xin Zhu,Hui Wang,Changbin Chen,Ning-Ning Liu
Nature communicationsno. 1 (2024)
JOURNAL OF NEUROCHEMISTRY (2024)
Tongyu Bi, Yunxia Cui,Shuai Liu,Haiyue Yu, Weirong Qiu, Ke-Qiang Hou, Jiaqi Zou, Zhipeng Yu, Feili Zhang,Zhongliang Xu,Jian Zhang,Xiaojun Xu,Weibo Yang
Angewandte Chemie (International ed. in English)pp.e202412296-e202412296, (2024)
Acta pharmaceutica sinica Bno. 3 (2024): 1302-1316
Journal of pharmaceutical and biomedical analysis (2024): 116073-116073
Organic & biomolecular chemistryno. 12 (2024): 2370-2374
CATALYSIS SCIENCE & TECHNOLOGYno. 10 (2024): 2772-2778
RSC medicinal chemistry (2024)
ORGANIC & BIOMOLECULAR CHEMISTRYno. 3 (2024): 472-476
Load More
Author Statistics
#Papers: 376
#Citation: 14023
H-Index: 63
G-Index: 107
Sociability: 7
Diversity: 0
Activity: 6
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn